Repligen Corporation announced it will release its third quarter 2026 financial results on October 27, 2026, before the market opens. The company will hold a conference call and webcast at 8:00 a.m. ET to discuss the results and business updates for the quarter ending September 30, 2026. Investors can access the call via phone or webcast on the company's website, with a replay available afterward. This update is important for stakeholders to assess Repligen's performance and outlook in the bioprocessing technology sector.
Repligen's upcoming Q3 2026 financial results are scheduled for release on October 27, 2026. For readers following the health sector, here is Pluang's market snapshot as of Oct 13, 2026 18:02 WIB: out of 128 priced health-sector US stocks, 78 rose and 41 fell. Johnson & Johnson traded at USD 256.82 with a 1-day change of -2.62%, and AstraZeneca plc was priced at USD 162.00, up 2.32%.
Existing-home sales in the U.S. increased by 1.5% month-over-month in September but declined 2.2% compared to the previous year, according to the National Association of Realtors. Sales rose in the South and West regions but fell in the Northeast and...
Columbus Marketing Experts, a digital marketing agency in Hilliard, Ohio, is expanding its local SEO services across Columbus to help service businesses improve their visibility on Google Search and Google Maps. The expansion aims to enhance local di...
Schrödinger's stock fell 5.02% to $25.91 despite co-founding Tectora, a new biopharma venture with $55 million funding targeting immune and inflammatory treatments. The company, known for its molecular modeling software, holds a market value of about...
Johnson & Johnson reported third-quarter 2026 earnings per share of $2.59, surpassing analyst estimates of $2.52, with total revenue of $25.40 billion slightly above expectations. The company saw robust growth in its pharmaceutical segment, which off...
Nvidia CEO Jensen Huang has reaffirmed his forecast that global spending on AI infrastructure will grow significantly, reaching between $3 trillion and $4 trillion by 2030. This projection highlights the massive potential and ongoing investment in AI...
